Global PET Radiopharmaceuticals Market Research Report 2023

Report ID: 1969896 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 PET Radiopharmaceuticals Market Overview
    1.1 Product Overview and Scope of PET Radiopharmaceuticals
    1.2 PET Radiopharmaceuticals Segment by Type
        1.2.1 Global PET Radiopharmaceuticals Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 F-18
        1.2.3 Ru-82
        1.2.4 Others
    1.3 PET Radiopharmaceuticals Segment by Application
        1.3.1 Global PET Radiopharmaceuticals Sales Comparison by Application: (2022-2028)
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Neurology
        1.3.5 Others
    1.4 Global PET Radiopharmaceuticals Market Size Estimates and Forecasts
        1.4.1 Global PET Radiopharmaceuticals Revenue 2017-2028
        1.4.2 Global PET Radiopharmaceuticals Sales 2017-2028
        1.4.3 PET Radiopharmaceuticals Market Size by Region: 2017 Versus 2021 Versus 2028
2 PET Radiopharmaceuticals Market Competition by Manufacturers
    2.1 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
    2.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers PET Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
    2.5 PET Radiopharmaceuticals Market Competitive Situation and Trends
        2.5.1 PET Radiopharmaceuticals Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest PET Radiopharmaceuticals Players Market Share by Revenue
        2.5.3 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PET Radiopharmaceuticals Retrospective Market Scenario by Region
    3.1 Global PET Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global PET Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America PET Radiopharmaceuticals Market Facts & Figures by Country
        3.3.1 North America PET Radiopharmaceuticals Sales by Country
        3.3.2 North America PET Radiopharmaceuticals Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe PET Radiopharmaceuticals Market Facts & Figures by Country
        3.4.1 Europe PET Radiopharmaceuticals Sales by Country
        3.4.2 Europe PET Radiopharmaceuticals Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific PET Radiopharmaceuticals Market Facts & Figures by Region
        3.5.1 Asia Pacific PET Radiopharmaceuticals Sales by Region
        3.5.2 Asia Pacific PET Radiopharmaceuticals Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America PET Radiopharmaceuticals Market Facts & Figures by Country
        3.6.1 Latin America PET Radiopharmaceuticals Sales by Country
        3.6.2 Latin America PET Radiopharmaceuticals Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa PET Radiopharmaceuticals Market Facts & Figures by Country
        3.7.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country
        3.7.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global PET Radiopharmaceuticals Historic Market Analysis by Type
    4.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    4.2 Global PET Radiopharmaceuticals Revenue Market Share by Type (2017-2022)
    4.3 Global PET Radiopharmaceuticals Price by Type (2017-2022)
5 Global PET Radiopharmaceuticals Historic Market Analysis by Application
    5.1 Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    5.2 Global PET Radiopharmaceuticals Revenue Market Share by Application (2017-2022)
    5.3 Global PET Radiopharmaceuticals Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Cardinal Health Inc. (U.S.)
        6.1.1 Cardinal Health Inc. (U.S.) Corporation Information
        6.1.2 Cardinal Health Inc. (U.S.) Description and Business Overview
        6.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio
        6.1.5 Cardinal Health Inc. (U.S.) Recent Developments/Updates
    6.2 Mallinckrodt plc (Ireland)
        6.2.1 Mallinckrodt plc (Ireland) Corporation Information
        6.2.2 Mallinckrodt plc (Ireland) Description and Business Overview
        6.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio
        6.2.5 Mallinckrodt plc (Ireland) Recent Developments/Updates
    6.3 GE Healthcare (U.K.)
        6.3.1 GE Healthcare (U.K.) Corporation Information
        6.3.2 GE Healthcare (U.K.) Description and Business Overview
        6.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolio
        6.3.5 GE Healthcare (U.K.) Recent Developments/Updates
    6.4 Lantheus Medical Imaging, Inc. (U.S.)
        6.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
        6.4.2 Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview
        6.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio
        6.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates
    6.5 Bayer AG (Germany)
        6.5.1 Bayer AG (Germany) Corporation Information
        6.5.2 Bayer AG (Germany) Description and Business Overview
        6.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio
        6.5.5 Bayer AG (Germany) Recent Developments/Updates
    6.6 Bracco Imaging S.p.A (Italy)
        6.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
        6.6.2 Bracco Imaging S.p.A (Italy) Description and Business Overview
        6.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolio
        6.6.5 Bracco Imaging S.p.A (Italy) Recent Developments/Updates
    6.7 Eczacibasi-Monrol Nuclear Products (Turkey)
        6.6.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
        6.6.2 Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview
        6.6.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio
        6.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates
    6.8 Nordion, Inc. (Canada)
        6.8.1 Nordion, Inc. (Canada) Corporation Information
        6.8.2 Nordion, Inc. (Canada) Description and Business Overview
        6.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolio
        6.8.5 Nordion, Inc. (Canada) Recent Developments/Updates
    6.9 Advanced Accelerator Applications S.A. (France)
        6.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
        6.9.2 Advanced Accelerator Applications S.A. (France) Description and Business Overview
        6.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolio
        6.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments/Updates
    6.10 IBA Molecular Imaging (Belgium)
        6.10.1 IBA Molecular Imaging (Belgium) Corporation Information
        6.10.2 IBA Molecular Imaging (Belgium) Description and Business Overview
        6.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio
        6.10.5 IBA Molecular Imaging (Belgium) Recent Developments/Updates
7 PET Radiopharmaceuticals Manufacturing Cost Analysis
    7.1 PET Radiopharmaceuticals Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
    7.4 PET Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 PET Radiopharmaceuticals Distributors List
    8.3 PET Radiopharmaceuticals Customers
9 PET Radiopharmaceuticals Market Dynamics
    9.1 PET Radiopharmaceuticals Industry Trends
    9.2 PET Radiopharmaceuticals Market Drivers
    9.3 PET Radiopharmaceuticals Market Challenges
    9.4 PET Radiopharmaceuticals Market Restraints
10 Global Market Forecast
    10.1 PET Radiopharmaceuticals Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of PET Radiopharmaceuticals by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of PET Radiopharmaceuticals by Type (2023-2028)
    10.2 PET Radiopharmaceuticals Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of PET Radiopharmaceuticals by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of PET Radiopharmaceuticals by Application (2023-2028)
    10.3 PET Radiopharmaceuticals Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of PET Radiopharmaceuticals by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of PET Radiopharmaceuticals by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global PET Radiopharmaceuticals Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global PET Radiopharmaceuticals Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global PET Radiopharmaceuticals Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global PET Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2021
    Table 5. Global PET Radiopharmaceuticals Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global PET Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market PET Radiopharmaceuticals Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers PET Radiopharmaceuticals Manufacturing Sites and Area Served
    Table 11. Manufacturers PET Radiopharmaceuticals Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PET Radiopharmaceuticals as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global PET Radiopharmaceuticals Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Table 17. Global PET Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global PET Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
    Table 19. North America PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 21. North America PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 23. Europe PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 25. Europe PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific PET Radiopharmaceuticals Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
    Table 31. Latin America PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 33. Latin America PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Country (2017-2022)
    Table 39. Global PET Radiopharmaceuticals Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global PET Radiopharmaceuticals Sales Market Share by Type (2017-2022)
    Table 41. Global PET Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global PET Radiopharmaceuticals Revenue Share by Type (2017-2022)
    Table 43. Global PET Radiopharmaceuticals Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2017-2022)
    Table 45. Global PET Radiopharmaceuticals Sales Market Share by Application (2017-2022)
    Table 46. Global PET Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global PET Radiopharmaceuticals Revenue Share by Application (2017-2022)
    Table 48. Global PET Radiopharmaceuticals Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Cardinal Health Inc. (U.S.) Corporation Information
    Table 50. Cardinal Health Inc. (U.S.) Description and Business Overview
    Table 51. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product
    Table 53. Cardinal Health Inc. (U.S.) Recent Developments/Updates
    Table 54. Mallinckrodt plc (Ireland) Corporation Information
    Table 55. Mallinckrodt plc (Ireland) Description and Business Overview
    Table 56. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product
    Table 58. Mallinckrodt plc (Ireland) Recent Developments/Updates
    Table 59. GE Healthcare (U.K.) Corporation Information
    Table 60. GE Healthcare (U.K.) Description and Business Overview
    Table 61. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. GE Healthcare (U.K.) PET Radiopharmaceuticals Product
    Table 63. GE Healthcare (U.K.) Recent Developments/Updates
    Table 64. Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
    Table 65. Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview
    Table 66. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product
    Table 68. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates
    Table 69. Bayer AG (Germany) Corporation Information
    Table 70. Bayer AG (Germany) Description and Business Overview
    Table 71. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Bayer AG (Germany) PET Radiopharmaceuticals Product
    Table 73. Bayer AG (Germany) Recent Developments/Updates
    Table 74. Bracco Imaging S.p.A (Italy) Corporation Information
    Table 75. Bracco Imaging S.p.A (Italy) Description and Business Overview
    Table 76. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product
    Table 78. Bracco Imaging S.p.A (Italy) Recent Developments/Updates
    Table 79. Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
    Table 80. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview
    Table 81. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product
    Table 83. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates
    Table 84. Nordion, Inc. (Canada) Corporation Information
    Table 85. Nordion, Inc. (Canada) Description and Business Overview
    Table 86. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product
    Table 88. Nordion, Inc. (Canada) Recent Developments/Updates
    Table 89. Advanced Accelerator Applications S.A. (France) Corporation Information
    Table 90. Advanced Accelerator Applications S.A. (France) Description and Business Overview
    Table 91. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product
    Table 93. Advanced Accelerator Applications S.A. (France) Recent Developments/Updates
    Table 94. IBA Molecular Imaging (Belgium) Corporation Information
    Table 95. IBA Molecular Imaging (Belgium) Description and Business Overview
    Table 96. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product
    Table 98. IBA Molecular Imaging (Belgium) Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. PET Radiopharmaceuticals Distributors List
    Table 102. PET Radiopharmaceuticals Customers List
    Table 103. PET Radiopharmaceuticals Market Trends
    Table 104. PET Radiopharmaceuticals Market Drivers
    Table 105. PET Radiopharmaceuticals Market Challenges
    Table 106. PET Radiopharmaceuticals Market Restraints
    Table 107. Global PET Radiopharmaceuticals Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 108. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global PET Radiopharmaceuticals Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global PET Radiopharmaceuticals Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 112. Global PET Radiopharmaceuticals Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global PET Radiopharmaceuticals Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global PET Radiopharmaceuticals Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 116. Global PET Radiopharmaceuticals Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global PET Radiopharmaceuticals Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of PET Radiopharmaceuticals
    Figure 2. Global PET Radiopharmaceuticals Market Share by Type in 2021 & 2028
    Figure 3. F-18 Product Picture
    Figure 4. Ru-82 Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global PET Radiopharmaceuticals Market Share by Application in 2021 & 2028
    Figure 7. Oncology
    Figure 8. Cardiology
    Figure 9. Neurology
    Figure 10. Others
    Figure 11. Global PET Radiopharmaceuticals Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global PET Radiopharmaceuticals Market Size (2017-2028) & (US$ Million)
    Figure 13. Global PET Radiopharmaceuticals Sales (2017-2028) & (K Pcs)
    Figure 14. PET Radiopharmaceuticals Sales Share by Manufacturers in 2021
    Figure 15. Global PET Radiopharmaceuticals Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest PET Radiopharmaceuticals Players: Market Share by Revenue in 2021
    Figure 17. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global PET Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Figure 19. Global PET Radiopharmaceuticals Sales Market Share by Region in 2021
    Figure 20. Global PET Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
    Figure 21. Global PET Radiopharmaceuticals Revenue Market Share by Region in 2021
    Figure 22. U.S. PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Taiwan PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Philippines PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Vietnam PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Mexico PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Brazil PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Argentina PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Turkey PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Saudi Arabia PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. UAE PET Radiopharmaceuticals Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Sales Market Share of PET Radiopharmaceuticals by Type (2017-2022)
    Figure 47. Manufacturing Cost Structure of PET Radiopharmaceuticals
    Figure 48. Manufacturing Process Analysis of PET Radiopharmaceuticals
    Figure 49. PET Radiopharmaceuticals Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)
Frequently Asked Questions
PET Radiopharmaceuticals report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PET Radiopharmaceuticals report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PET Radiopharmaceuticals report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Functional Silanes

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More